| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 55/12/15 | 102/12/25 | 黃柏熊 | 黃柏熊 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.75(Q2) | 34.76 | 3.21 | 2.09% |
| 實收資本額 | 已發行普通股 | ||
| 400,187,500 | 40,018,750 | ||
| 主要經營業務 | |||
| 西藥之製造，加工，買賣，批發零售，進出口。營養保健食品之加工買賣。 | |||
| 公司網址 | |||
| jcpjohnson.com.tw | |||
強生(4747) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 52,780 | 39,666 | 13.6% | 33.1% | 403,192 | 310,465 | 29.9% |
| 2023/07 | 46,456 | 43,840 | -27% | 6% | 350,412 | 270,799 | 29.4% |
| 2023/06 | 63,678 | 41,947 | 27.5% | 51.8% | 303,956 | 226,959 | 33.9% |
| 2023/05 | 49,963 | 37,791 | 20.2% | 32.2% | 240,278 | 185,012 | 29.9% |
| 2023/04 | 41,567 | 36,819 | -32.3% | 12.9% | 190,315 | 147,221 | 29.3% |
| 2023/03 | 61,384 | 36,129 | 61.5% | 69.9% | 148,748 | 110,402 | 34.7% |
| 2023/02 | 38,014 | 34,567 | -23% | 10% | 87,364 | 74,273 | 17.6% |
| 2023/01 | 49,350 | 39,706 | -6% | 24.3% | 49,350 | 39,706 | 24.3% |
| 2022/12 | 52,523 | 37,113 | 19% | 41.5% | 494,671 | 411,491 | 20.2% |
| 2022/11 | 44,150 | 34,902 | -0.7% | 26.5% | 442,148 | 374,378 | 18.1% |
| 2022/10 | 44,463 | 34,485 | 3.2% | 28.9% | 397,998 | 339,476 | 17.2% |
| 2022/09 | 43,070 | 35,177 | 8.6% | 22.4% | 353,535 | 304,991 | 15.9% |
| 2022/08 | 39,666 | 33,016 | -9.5% | 20.1% | 310,465 | 269,814 | 15.1% |
| 2022/07 | 43,840 | 32,158 | 4.5% | 36.3% | 270,799 | 236,798 | 14.4% |
| 2022/06 | 41,947 | 31,940 | 11% | 31.3% | 226,959 | 204,640 | 10.9% |
| 2022/05 | 37,791 | 34,620 | 2.6% | 9.1% | 185,012 | 172,700 | 7.1% |
| 2022/04 | 36,819 | 32,295 | 1.9% | 14% | 147,221 | 138,080 | 6.6% |
| 2022/03 | 36,129 | 33,805 | 4.5% | 6.9% | 110,402 | 105,785 | 4.4% |
| 2022/02 | 34,567 | 31,978 | -12.9% | 8.1% | 74,273 | 71,980 | 3.2% |
| 2022/01 | 39,706 | 40,002 | 7% | -0.7% | 39,706 | 40,002 | -0.7% |
| 2021/12 | 37,113 | 38,846 | 6.3% | -4.5% | 411,491 | 424,015 | -3% |
| 2021/11 | 34,902 | 31,162 | 1.2% | 12% | 374,378 | 385,169 | -2.8% |
| 2021/10 | 34,485 | 33,420 | -2% | 3.2% | 339,476 | 354,007 | -4.1% |
| 2021/09 | 35,177 | 31,726 | 6.5% | 10.9% | 304,991 | 320,587 | -4.9% |
| 2021/08 | 33,016 | 32,726 | 2.7% | 0.9% | 269,814 | 288,861 | -6.6% |
| 2021/07 | 32,158 | 40,890 | 0.7% | -21.4% | 236,798 | 256,135 | -7.5% |
| 2021/06 | 31,940 | 31,393 | -7.7% | 1.7% | 204,640 | 215,245 | -4.9% |
| 2021/05 | 34,620 | 28,434 | 7.2% | 21.8% | 172,700 | 183,852 | -6.1% |
| 2021/04 | 32,295 | 37,632 | -4.5% | -14.2% | 138,080 | 155,418 | -11.1% |
| 2021/03 | 33,805 | 43,567 | 5.7% | -22.4% | 105,785 | 117,786 | -10.2% |
| 2021/02 | 31,978 | 39,050 | -20% | -18.1% | 71,980 | 74,219 | -3% |
| 2021/01 | 40,002 | 35,169 | 3% | 13.7% | 40,002 | 35,169 | 13.7% |
| 2020/12 | 38,846 | 47,653 | 24.6% | -18.5% | 424,015 | 425,339 | -0.3% |
| 2020/11 | 31,162 | 35,996 | -6.8% | -13.4% | 385,169 | 377,686 | 2% |
| 2020/10 | 33,420 | 40,548 | 5.3% | -17.6% | 354,007 | 341,690 | 3.6% |
| 2020/09 | 31,726 | 30,487 | -3% | 4.1% | 320,587 | 301,142 | 6.4% |
強生(4747) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 4.34% | 7.25% | 2020Q3 | 8.09% | 1.58% |
| 2023Q1 | 5.39% | 7.75% | 2020Q2 | -17.26% | -0.86% |
| 2022Q4 | 11.50% | 7.53% | 2020Q1 | -5.16% | 3.83% |
| 2022Q3 | 8.60% | 6.05% | 2019Q4 | 26.21% | 3.55% |
| 2022Q2 | 5.58% | 4.25% | 2019Q3 | -2.81% | 0.26% |
| 2022Q1 | 3.66% | 1.12% | 2019Q2 | -0.25% | -0.51% |
| 2021Q4 | 6.13% | 0.75% | 2019Q1 | -7.40% | -0.03% |
| 2021Q3 | 1.51% | -1.21% | 2018Q4 | 12.61% | 1.78% |
| 2021Q2 | -6.55% | 0.34% | 2018Q3 | -5.83% | -0.58% |
| 2021Q1 | 2.28% | -2.83% | 2018Q2 | 1.70% | 1.20% |
| 2020Q4 | -1.82% | -4.67% | 2018Q1 | -0.74% | 1.94% |
評論0